refractory solid tumour
Recently Published Documents

TOTAL DOCUMENTS

5

(FIVE YEARS 3)

H-INDEX

2

(FIVE YEARS 1)

Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1–2 trial

The Lancet Oncology ◽

10.1016/s1470-2045(19)30671-0 ◽

2020 ◽

Vol 21 (1) ◽

pp. 121-133 ◽

Author(s):

Birgit Geoerger ◽

Hyoung Jin Kang ◽

Michal Yalon-Oren ◽

Lynley V Marshall ◽

Catherine Vezina ◽

...

Keyword(s):

Interim Analysis ◽

Solid Tumour ◽

Phase 1 ◽

Advanced Melanoma ◽

Paediatric Patients ◽

Refractory Solid Tumour

Download Full-text

The mutant neoantigen specific T cell is a personalized immunotherapy in refractory solid tumour

Annals of Oncology ◽

10.1093/annonc/mdz253.054 ◽

2019 ◽

Vol 30 ◽

pp. v502

Author(s):

Q. Song ◽

T. Zhang ◽

J. Li ◽

W. Sheng ◽

J. Wang ◽

...

Keyword(s):

T Cell ◽

Solid Tumour ◽

Refractory Solid Tumour

Download Full-text

Haplo / Allogeneic NKG2DL-targeting Chimeric Antigen Receptor-grafted γδ T Cells for Relapsed or Refractory Solid Tumour

Case Medical Research ◽

10.31525/ct1-nct04107142 ◽

2019 ◽

Author(s):

Keyword(s):

T Cells ◽

Chimeric Antigen Receptor ◽

Solid Tumour ◽

Antigen Receptor ◽

Γδ T Cells ◽

Refractory Solid Tumour

Download Full-text

A phase I trial of figitumumab in children with relapsed/refractory solid tumour

http://isrctn.org/> ◽

10.1186/isrctn12655440 ◽

2012 ◽

Author(s):

Kathy Pritchard-Jones

Keyword(s):

Phase I ◽

Solid Tumour ◽

Phase I Trial ◽

Refractory Solid Tumour

Download Full-text

Thalidomide therapy in refractory solid tumour patients

British Journal of Haematology ◽

10.1046/j.1365-2141.2000.02239-11.x ◽

2000 ◽

Vol 110 (3) ◽

pp. 754-754 ◽

Author(s):

J. Gutheil ◽

D. Finucane

Keyword(s):

Solid Tumour ◽

Refractory Solid Tumour

Download Full-text